CeoPayFacts
Get updates

Revance Therapeutics (RVNC) CEO pay: $6.3M actually paid in FY2023

$RVNC · Revance Therapeutics, Inc.
CIK 1479290Latest filing

Data through FY2023 — latest proxy filed 2024-03-21, checked for new filings 2026-08-21. Every number links to its source.

1.6× the tracked-company median CEO pay ($3.9M).

Pay vs. Performance (Compensation Actually Paid)

What the CEO was actually paid, by fiscal year

CEO pay actually earned$26.3M$16.1M$5.9M-$4.2M-$14.4M20202023CEO pay actually earned

A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated

What $100 invested was worth, company vs peer group

This company vs Peer group$174.61$144.50$114.39$84.27$54.1620202023This companyPeer group

Pay-vs-Performance table

FYCEO pay on paperCEO pay actually earnedOther top execs (avg)Value of $100 invested since FY2020Same, peer group since FY2020Net income
2023$10.1M$6.3M$2.8M$54.16$115.42-$324.0M
2022$6.6M$14.6M$3.2M$113.74$111.27-$356.4M
2021$7.1M-$14.4M-$18,373$100.55$124.89-$281.3M
2020$8.8M$26.3M$4.8M$174.61$125.69-$282.1M

A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated

View Revance Therapeutics, Inc.'s filing

Frequently asked

How much did the RVNC CEO make in 2023?

$6,293,718 in Compensation Actually Paid (CAP) as Revance Therapeutics, Inc.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2024-03-21.

What is pay vs. performance (PvP)?

An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.

What is Compensation Actually Paid (CAP)?

CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.

Also on RVNC: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary